The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
VEGF as a Mediator of Tumor-Associated Immunodeficiency
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628
Vascular endothelial growth factor (VEGF) and its receptors
NEUFELD, G., COHEN, T., GENGRINOVITCH, S., & POLTORAK, Z. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.9 · Cited by 3,483
Baeuerle, P. A., & Baltimore, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81318-5 · Cited by 3,001
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977
Self-citationRel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.
Verma, I. M., Stevenson, J. K., Schwarz, E. M., Van Antwerp, D., & Miyamoto, S. (1995) · Genes & Development · doi:10.1101/gad.9.22.2723 · Cited by 1,724
Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of Proteins
FERRARA, N., HOUCK, K., JAKEMAN, L., & LEUNG, D. W. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-18 · Cited by 1,655
NF-κB: A lesson in family values
Thanos, D., & Maniatis, T. (1995) · Cell · doi:10.1016/0092-8674(95)90506-5 · Cited by 1,247
Tumor Antigens Recognized by T Lymphocytes
Boon, T., Cerottini, J.-C., Van den Eynde, B., van der Bruggen, P., & Van Pel, A. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.002005 · Cited by 1,221
Hiratsuka, S., Minowa, O., Kuno, J., Noda, T., & Shibuya, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9349 · Cited by 1,062
Gabrilovich, D., Ishida, T., Oyama, T., Ran, S., Kravtsov, V., Nadaf, S., & Carbone, D. P. (1998) · Blood · doi:10.1182/blood.v92.11.4150 · Cited by 1,048
Self-citationHuman tumor antigens recognized by T lymphocytes.
Boon, T., & van der Bruggen, P. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.725 · Cited by 842
Clinical significance of defective dendritic cell differentiation in cancer.
Almand, B., Resser, J. R., Lindman, B. R., Nadaf, S., Clark, J. I., Kwon, E. D., Carbone, D. P., & Gabrilovich, D. I. (2000) · PubMed · Cited by 699
Self-citationOyama, T., Ran, S., Ishida, T., Nadaf, S., Kerr, L. D., Carbone, D. P., & Gabrilovich, D. I. (1998) · PubMed · Cited by 530
Self-citationNF-κB Activation: The IκB Kinase Revealed?
Stancovski, I., & Baltimore, D. (1997) · Cell · doi:10.1016/s0092-8674(00)80413-4 · Cited by 492
KDR Receptor: A Key Marker Defining Hematopoietic Stem Cells
Ziegler, B. L., Valtieri, M., Porada, G. A., Maria, R. D., Müller, R., Masella, B., Gabbianelli, M., Casella, I., Pelosi, E., Bock, T., et al. (1999) · Science · doi:10.1126/science.285.5433.1553 · Cited by 486
Gabrilovich, D. I., Ishida, T., Nadaf, S., Ohm, J. E., & Carbone, D. P. (1999) · PubMed · Cited by 459
Self-citationCoulie, P. G., Lehmann, F., Lethé, B., Herman, J., Lurquin, C., Andrawiss, M., & Boon, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7976 · Cited by 423
Toi, M., Hoshina, S., Takayanagi, T., & Tominaga, T. (1994) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1994.tb02904.x · Cited by 391
Katoh, O., Tauchi, H., Kawaishi, K., Kimura, A., & Satow, Y. (1995) · PubMed · Cited by 303
Sieczkiewicz, G. J., Hussain, M., & Kohn, E. C. (2002) · Ovarian Cancer · doi:10.1007/978-1-4757-3587-1_17 · Cited by 295
Ellis, L. M., & Fidler, I. J. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00389-9 · Cited by 293
The NF-κB/Rel and IκB gene families: mediators of immune response and inflammation
Wulczyn, F. G., Krappmann, D., & Scheidereit, C. (1996) · Journal of Molecular Medicine · doi:10.1007/s001090050078 · Cited by 256
Tumor-induced immune dysfunction
Kiessling, R., Wasserman, K., Horiguchi, S., Kono, K., Sjöberg, J., Pisa, P., & Petersson, M. (1999) · Cancer Immunology, Immunotherapy · doi:10.1007/s002620050586 · Cited by 237
Dendritic Cells in Antitumor Immune Responses
Gabrilovich, D. I., Nadaf, S., Corak, J., Berzofsky, J. A., & Carbone, D. P. (1996) · Cellular Immunology · doi:10.1006/cimm.1996.0140 · Cited by 213
Self-citationKondo, S., Asano, M., Matsuo, K., Ohmori, I., & Suzuki, H. (1994) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(94)90016-7 · Cited by 191
Johnsen, A. K., Templeton, D. J., Sy, M.-S., & Harding, C. V. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4224 · Cited by 173
Where have all the T cells gone? Mechanisms of immune evasion by tumors
Finke, J. H., Ferrone, S., Frey, A. B., Mufson, A., & Ochoa, A. C. (1999) · Immunology Today · doi:10.1016/s0167-5699(98)01435-2 · Cited by 150
Ishida, T., Oyama, T., Carbone, D. P., & Gabrilovich, D. I. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4842 · Cited by 150
Self-citationToward a Genetic Analysis of Tumor Rejection Antigens
Boon, T. (1992) · Advances in cancer research · doi:10.1016/s0065-230x(08)60295-x · Cited by 146
Myeloid progenitor cell regulatory effects of vascular endothelial cell growth factor.
Broxmeyer (1995) · International Journal of Hematology · doi:10.1016/0925-5710(95)00412-2 · Cited by 112
Clinical significance of the determination of angiogenic factors
Toi, M., Taniguchi, T., Yamamoto, Y., Kurisaki, T., Suzuki, H., & Tominaga, T. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00397-8 · Cited by 107
IL‐1 and IL‐6 release by tumor‐associated macrophages from human ovarian carcinoma
Erroi, A., Sironi, M., Chiaffarino, F., et al. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910440508 · Cited by 98
Grossmann, M., Nakamura, Y., Grumont, R. J., & Gerondakis, S. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00068-0 · Cited by 78
Escape from Host-Antitumor Immunity
Pawelec, G., Zeuthen, J., & Kiessling, R. W. (1997) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v8.i2-3.10 · Cited by 78
IMMUNOLOGIC DYSFUNCTION IN CANCER
Yardley, D. A., & Carbone, D. P. (1996) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70376-2 · Cited by 76
Self-citationHoehn, G., Stokland, T., Amin, S., et al. (1996) · PubMed · Cited by 62
Watson, G. A., & Lopez, D. M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.6.3124 · Cited by 61
Immunologic Nonresponsiveness to Tumors
Extermann, M., Antonia, S. J., & Flavell, R. A. (1998) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v9.i1.30 · Cited by 53
The immune system as anti-tumor sentinel: molecular requirements for an anti-tumor immune response.
Markiewicz, M. A., & Gajewski, T. F. (1999) · PubMed · Cited by 50
Alcalay, J., & Kripke, M. L. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.6.1717 · Cited by 43
Erroi, A., Casali, B., Donati, M. B., et al. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410113 · Cited by 7
Cited by
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
VEGF in signaling and disease: beyond discovery and development
Apte, R. S., Chen, D. S., & Ferrara, N. (2019) · Cell · doi:10.1016/j.cell.2019.01.021 · Cited by 2,721
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion
Jhunjhunwala, S., Hammer, C., & Delamarre, L. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00339-z · Cited by 1,490
Combination cancer immunotherapy and new immunomodulatory targets
Mahoney, K. M., Rennert, P. D., & Freeman, G. J. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4591 · Cited by 1,294
Metadata
- Authors
- Ohm, J. E., & Carbone, D. P.
- Venue
- Immunologic Research
- Published
- 2001
- Volume
- 23
- Issue
- 2-3
- Pages
- 263-272
- ISSN
- 0257-277X (ISSN-L)
- OpenAlex
- W1995483670
- Cited by
- 371
- References
- 45
- FWCI
- 3.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.